Menu

Welcome to the Anteris Investor Center, your hub for financial updates and company news.

Welcome to the Anteris Investor Centre, your hub for financial updates and company news.

Financial Filings

Access the latest SEC Filings (Nasdaq: AVR) and ASX Announcements (ASX: AVR) 

SEC Filings

Filing Date Form Description Actions
  • JAN 23
    Form: 3
    Initial statement of beneficial ownership of securities
  • JAN 23
    Form: SCHEDULE 13G
    Statement of acquisition of beneficial ownership by individuals
  • JAN 15
    Form: 8-K
    Current report pursuant to Section 13 or 15(d)
View all

ASX Announcements
View all

Corporate Profile

Anteris Technologies is a structural heart company committed to designing, developing, and commercialising innovative medical devices.

 

Designed with physicians for patients, our DurAVR® Transcatheter Heart Valve (THV) uses a single-piece, native-shaped biomimetic design built to mimic the performance of a healthy aortic valve. 

Anteris Technologies is a structural heart company

Sign-Up for ASX Investor Email Alerts

Sign up

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.

Our Technologies

The DurAVR® THV System

The DurAVR® Transcatheter Heart Valve (THV) System delivers outstanding hemodynamic results combined with the deliverability performance of a balloon-expandable system. The System includes the DurAVR® Transcatheter Heart Valve, the ADAPT® anti-calcification tissue, and the ComASUR® Delivery System.  

Our Technology

For more information, contact Investor Relations 
investors@anteristech.com